Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis
Biotech
Novartis secures new radioligand in $900M deal
Novartis licensed a preclinical radioligand from a Chinese biotech the day after Telix announced plans to buy Novartis' isotope supplier ITM.
Darren Incorvaia
Sep 22, 2026 1:22pm
Novartis ends ALS program after phase 2 flop, adding to R&D woes
Sep 16, 2026 10:28am
Novartis pays Sironax $125M to acquire brain delivery platform
Sep 16, 2026 8:32am
Fierce Pharma
Novartis investor calls for board overhaul after costly setbacks
Sep 10, 2026 10:26am
Novartis’ centerpiece of $12B Avidity deal flunks ‘crucial’ test
Sep 8, 2026 3:34am
Novartis Lp(a) drug fails closely watched ph. 3 trial
Sep 4, 2026 9:18pm
